A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults

• Status: Completed
• Trial end date: 2018-10-17

Summary

This was a 3-part study with each part being an open-label, fixed-sequence, 2-period study in healthy adult participants.

• Phase: Phase 1

Details

• Lead Sponsor: Alexion Pharmaceuticals
• Collaborator: Achillion, a wholly owned subsidiary of Alexion
• Treatments: Aluminum hydroxide, magnesium hydroxide, drug combination; Antacids; Anti-Ulcer Agents; Calcium Carbonate; Cyclosporine; Cyclosporins; Magnesium Hydroxide; Omeprazole; Simethicone; Tacrolimus